publications | Catherinn
PLOS ONE: Benchmarking of Mutation Diagnostics in Clinical Lung Cancer Specimens
Clinical Lung Cancer | Journal | ScienceDirect.com by Elsevier
Clinical Lung Cancer - Wikipedia
Clinical Lung Cancer (@ClinicalLung) / Twitter
Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non–Small-Cell Lung Cancer - Clinical Lung Cancer
Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non–small-cell Lung Cancer - Clinical Lung Cancer
Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non–Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical Considerations - Clinical Lung Cancer
PDF) Treatment Patterns and Clinical Outcomes Among Metastatic Non-Small Cell Lung Cancer Patients Treated in the Community Practice Setting
CHCWM clinical trial published in esteemed lung cancer journal - CHCWM - Cancer & Hematology Centers of West Michigan
Prevalence of clinical lung diseases by smoking status and pack-years... | Download Scientific Diagram
PDF) The Role of Performance Status in Small-Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors
Home Page: Clinical Lung Cancer
Outcomes of Patients With Interstitial Lung Disease Receiving Programmed Cell Death 1 Inhibitors: A Retrospective Case Series - Clinical Lung Cancer
Clinical Lung Cancer | Vol 6, Suppl 1, Pages S6-S47 (December 2004) | ScienceDirect.com by Elsevier
Clinical Lung Cancer | Elsevier Pharma Solutions
Clinical Lung Cancer | Vol 9, Issue 4, Pages 192-238 (July 2008) | ScienceDirect.com by Elsevier
Clinical Activity of Afatinib in Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study - Clinical Lung Cancer
Major Clinical Response to Afatinib Monotherapy in Lung Adenocarcinoma Harboring EGFR Exon 20 Insertion Mutation - Clinical Lung Cancer
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy - ScienceDirect
Platinum Re-Exposure as a Non-Small Cell Lung Cancer (NSCLC) Treatment Strategy in the Age of Immunotherapy - Clinical Lung Cancer
PSAT1 expression in normal and tumor tissues derived from clinical lung... | Download Scientific Diagram
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave - ScienceDirect
David Gandara on Twitter: "Nov issue of Clinical Lung Cancer features review on Oligometastaic NSCLC by Popat et al. Worth reading. https://t.co/6aLd3almi5" / Twitter
Overall Survival and Safety With Pemetrexed/Platinum ± Anti-VEGF Followed by Pemetrexed ± Anti-VEGF Maintenance in Advanced Nonsquamous Non–Small-Cell Lung Cancer: A Pooled Analysis of 4 Randomized Studies - Clinical Lung Cancer
Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non–Small Cell Lung Cancer - Journal of Thoracic Oncology
